SCHEMBL15427882

SCHEMBL15427882

Cc1cc2ccnc(Cl)c2cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.40
CCR1 P32246 3/20 0.40
CCR8 P51685 3/20 0.40
MAPT P10636 2/20 0.40
PARG Q86W56 1/20 0.40
LMNA P02545 1/20 0.40
APEX1 P27695 1/20 0.40
MAPK1 P28482 1/20 0.40
PMP22 Q01453 1/20 0.40
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP2D6 P10635 1/20 0.38
HIPK2 Q9H2X6 1/20 0.37
CYP2A6 P11509 2/20 0.36
POLB P06746 1/20 0.36
CCR5 P51681 2/20 0.35
ALDH1A1 P00352 3/20 0.35
GRM4 Q14833 1/20 0.35
KDM4E B2RXH2 3/20 0.33
TNF P01375 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18300448 0.88 PARG (0.38) CYP3A4CCR1CCR8MAPTPARG
SCHEMBL28969092 0.85 CYP3A4 (0.56) CYP3A4CCR1CCR8MAPTPARG
SCHEMBL30353608 0.85 CYP3A4 (0.56) CYP3A4CCR1CCR8MAPTPARG
SCHEMBL25369992 0.85 TERT (0.41) CYP3A4CCR1CCR8MAPTPARG
SCHEMBL15428069 0.85 PARG (0.37) CYP3A4CCR1CCR8MAPTPARG
SCHEMBL7214223 0.85 CYP3A4 (0.38) CYP3A4MAPTPARGLMNAAPEX1
SCHEMBL1205625 0.82 TNF (0.47) CYP3A4MAPTLMNAMAPK1PMP22
SCHEMBL28551219 0.81 ALDH1A1 (0.46) CYP3A4MAPTPARGLMNAAPEX1
SCHEMBL15124778 0.80 LMNA (0.44) CYP3A4CCR1CCR8MAPTPARG
SCHEMBL30576347 0.80 LMNA (0.44) CYP3A4CCR1CCR8MAPTPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100534986-C Method for preparing derivative of 1,4 - dichloro isoquinoline category UNIV ZHEJIANG POLYTECHNIC (CN) 2009-09-02 CN claimed
CN-101092395-A Method for preparing derivative of 1,4 - dichloro isoquinoline category UNIV ZHEJIANG POLYTECHNIC (CN) 2007-12-26 CN claimed
US-9837622-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-05 US disclosed
US-9837622-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-05 US disclosed
US-20150263297-A1 Metal Complexes MERCK PATENT GMBH (DE) 2015-09-17 US disclosed
US-20150263297-A1 Metal Complexes MERCK PATENT GMBH (DE) 2015-09-17 US disclosed
WO-2014008982-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2014-01-16 WO disclosed
CN-100534986-C Method for preparing derivative of 1,4 - dichloro isoquinoline category UNIV ZHEJIANG POLYTECHNIC (CN) 2009-09-02 CN disclosed
CN-101092395-A Method for preparing derivative of 1,4 - dichloro isoquinoline category UNIV ZHEJIANG POLYTECHNIC (CN) 2007-12-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150263297-A1 Metal Complexes SOD1, AP1M1, AP3M1 CYP3A4 2252/4885CCR1 2964/4885CCR8 2583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.